Journal of Experimental & Clinical Cancer Research operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
After initial review for suitability, submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
The journal aims to provide authors with a first decision (accepted/rejected/revisions needed) within six weeks.
Owned by the Association for International Promotion & Study in Tumors (APSIT)
Official journal of the Regina Elena National Cancer Institute, Scientific Director Gennaro Ciliberto, Rome, Italy
- Editorial Board
- Sign up for article alerts and news from this journal
Annual Journal Metrics
27 days to first decision for reviewed manuscripts only
33 days to first decision for all manuscripts
97 days from submission to acceptance
21 days from acceptance to publication
6.217 - 2-year Impact Factor
5.280 - 5-year Impact Factor
1.350 - Source Normalized Impact per Paper (SNIP)
2.000 - SCImago Journal Rank (SJR)
392 Altmetric Mentions